Neurocrine Biosciences (NBIX) Tax Provisions: 2019-2021
Historic Tax Provisions for Neurocrine Biosciences (NBIX) over the last 3 years, with Sep 2021 value amounting to $8.0 million.
- Neurocrine Biosciences' Tax Provisions rose 1500.00% to $8.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.8 million, marking a year-over-year increase of 83.77%. This contributed to the annual value of $9.5 million for FY2019, which is 1205.48% up from last year.
- Neurocrine Biosciences' Tax Provisions amounted to $8.0 million in Q3 2021, which was down 47.37% from $15.2 million recorded in Q2 2021.
- In the past 5 years, Neurocrine Biosciences' Tax Provisions registered a high of $15.2 million during Q2 2021, and its lowest value of -$4.9 million during Q1 2021.
- Moreover, its 3-year median value for Tax Provisions was $2.5 million (2020), whereas its average is $3.3 million.
- Examining YoY changes over the last 5 years, Neurocrine Biosciences' Tax Provisions showed a top increase of 1,500.00% in 2021 and a maximum decrease of 426.67% in 2021.
- Over the past 3 years, Neurocrine Biosciences' Tax Provisions (Quarterly) stood at $4.6 million in 2019, then slumped by 89.13% to $500,000 in 2020, then soared by 1,500.00% to $8.0 million in 2021.
- Its Tax Provisions stands at $8.0 million for Q3 2021, versus $15.2 million for Q2 2021 and -$4.9 million for Q1 2021.